These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 38136750)

  • 1. Lipid-Centric Approaches in Combating Infectious Diseases: Antibacterials, Antifungals and Antivirals with Lipid-Associated Mechanisms of Action.
    Ostroumova OS; Efimova SS
    Antibiotics (Basel); 2023 Dec; 12(12):. PubMed ID: 38136750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporation of Antibiotics into Solid Lipid Nanoparticles: A Promising Approach to Reduce Antibiotic Resistance Emergence.
    Arana L; Gallego L; Alkorta I
    Nanomaterials (Basel); 2021 May; 11(5):. PubMed ID: 34068834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EML webinar overview: Simulation-assisted discovery of membrane targeting nanomedicine.
    Zou G; Liu Y; Gao H
    Extreme Mech Lett; 2020 Sep; 39():100817. PubMed ID: 32537481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Neutrally Charged Diarylurea Compound PQ401 Kills Antibiotic-Resistant and Antibiotic-Tolerant Staphylococcus aureus.
    Kim W; Zou G; Pan W; Fricke N; Faizi HA; Kim SM; Khader R; Li S; Lee K; Escorba I; Vlahovska PM; Gao H; Ausubel FM; Mylonakis E
    mBio; 2020 Jun; 11(3):. PubMed ID: 32605985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unlocking the bacterial membrane as a therapeutic target for next-generation antimicrobial amphiphiles.
    Mehta D; Saini V; Aggarwal B; Khan A; Bajaj A
    Mol Aspects Med; 2021 Oct; 81():100999. PubMed ID: 34325929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,3-Thiazine, 1,2,3,4-Dithiadiazole, and Thiohydrazide Derivatives Affect Lipid Bilayer Properties and Ion-Permeable Pores Induced by Antifungals.
    Zakharova AA; Efimova SS; Yuskovets VN; Yakovlev IP; Sarkisyan ZM; Ostroumova OS
    Front Cell Dev Biol; 2020; 8():535. PubMed ID: 32695784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?
    Zharkova MS; Orlov DS; Golubeva OY; Chakchir OB; Eliseev IE; Grinchuk TM; Shamova OV
    Front Cell Infect Microbiol; 2019; 9():128. PubMed ID: 31114762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives on Usage of Functional Nanomaterials in Antimicrobial Therapy for Antibiotic-Resistant Bacterial Infections.
    Karnwal A; Kumar G; Pant G; Hossain K; Ahmad A; Alshammari MB
    ACS Omega; 2023 Apr; 8(15):13492-13508. PubMed ID: 37091369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polydim-I antimicrobial activity against MDR bacteria and its model membrane interaction.
    Rangel M; Castro FFDS; Mota-Lima LD; Clissa PB; Martins DB; Cabrera MPDS; Mortari MR
    PLoS One; 2017; 12(6):e0178785. PubMed ID: 28570651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current status of phage therapy and its advancement towards establishing standard antimicrobials for combating multi drug-resistant bacterial pathogens.
    Ali Y; Inusa I; Sanghvi G; Mandaliya VB; Bishoyi AK
    Microb Pathog; 2023 Aug; 181():106199. PubMed ID: 37336428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational approaches towards inorganic and organometallic antibacterials.
    Hess J
    Biol Chem; 2022 Mar; 403(4):363-375. PubMed ID: 34253000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plant phenolics and terpenoids as adjuvants of antibacterial and antifungal drugs.
    Zacchino SA; Butassi E; Liberto MD; Raimondi M; Postigo A; Sortino M
    Phytomedicine; 2017 Dec; 37():27-48. PubMed ID: 29174958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Mechanisms of Action of Triindolylmethane Derivatives on Lipid Membranes.
    Efimova SS; Tertychnaya TE; Lavrenov SN; Ostroumova OS
    Acta Naturae; 2019; 11(3):38-45. PubMed ID: 31720015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanozybiotics: Nanozyme-Based Antibacterials against Bacterial Resistance.
    Zhou C; Wang Q; Jiang J; Gao L
    Antibiotics (Basel); 2022 Mar; 11(3):. PubMed ID: 35326853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial Peptides and their Pore/Ion Channel Properties in Neutralization of Pathogenic Microbes.
    Sharma S; Sahoo N; Bhunia A
    Curr Top Med Chem; 2016; 16(1):46-53. PubMed ID: 26139119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transition Towards Antibiotic Hybrid Vehicles: The Next Generation Antibacterials.
    Kuppusamy R; Browne K; Suresh D; Do Rosario RM; Chakraborty S; Yang S; Willcox M; Black D; Chen R; Kumar N
    Curr Med Chem; 2022; 30(1):104-125. PubMed ID: 35702780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into the resistance mechanism for the BceAB-type transporter SaNsrFP.
    Gottstein J; Zaschke-Kriesche J; Unsleber S; Voitsekhovskaia I; Kulik A; Behrmann LV; Overbeck N; Stühler K; Stegmann E; Smits SHJ
    Sci Rep; 2022 Mar; 12(1):4232. PubMed ID: 35273305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of membrane perturbation by antimicrobial peptides and the use of biophysical studies in the design of novel peptide antibiotics.
    Lohner K; Blondelle SE
    Comb Chem High Throughput Screen; 2005 May; 8(3):241-56. PubMed ID: 15892626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics.
    Mubeen B; Ansar AN; Rasool R; Ullah I; Imam SS; Alshehri S; Ghoneim MM; Alzarea SI; Nadeem MS; Kazmi I
    Antibiotics (Basel); 2021 Nov; 10(12):. PubMed ID: 34943685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic Resistance: Challenges and Strategies in Combating Infections.
    Chavada J; Muneshwar KN; Ghulaxe Y; Wani M; Sarda PP; Huse S
    Cureus; 2023 Sep; 15(9):e46013. PubMed ID: 37900415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.